SignalPath Raises $18M Series B to Streamline Clinical Trial Management
SignalPath has raised an $18 million Series B round to expand its team. The company did not reveal the round's investors. The funding will support SignalPath's more than 250 research sites and brings the Raleigh-based healthtech startup's total investment to $35 million.
"As